Jared Dashevsky - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jared Dashevsky's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jared Dashevsky

Jared Dashevsky

Verified

Writer, Healthcare Huddle

New York

Final Covers

Breaking News CrimePolitics Data Reporting

Doesn’t Cover

Fashion and celebrities

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 113

  • Cost Plus Drugs Partnerships: Cutting Drug Costs for Health Systems

    By Jared Dashevsky| healthcarehuddle.com@ GRAND ROUNDSMark Cuban’s Cost Plus Drugs Company just announced a new partnership with Penn Medicine—their third health system partnership in under a year. If you’ve been a Huddler for a while, you know I’m a big fan of Cost Plus Drugs. Back in February 2024, I broke down their business model and why it’s shaking up the drug pricing game. With this latest partnership making headlines, it’s the perfect time to dive back into Cost Plus Drugs.

    By Jared Dashevsky · healthcarehuddle.com

    Dec. 08, 2024

  • CMS Negotiates Drug Prices: The Not-so-Clear Impact on Medicare Spending

    By Jared Dashevsky| healthcarehuddle.com@ GRAND ROUNDSThe Centers for Medicare and Medicaid Services (CMS) can finally negotiate drug prices, a significant shift after years of being prohibited—a restriction that many believe contributed to the soaring cost of medications. CMS has been preparing for these negotiations for the past two years, targeting ten high-cost drugs. Now, the newly negotiated prices have been unveiled. So, how do these prices measure up?

    By Jared Dashevsky · healthcarehuddle.com

    Aug. 18, 2024

  • Cost Plus Drugs Partnerships: Cutting Drug Costs for Health Systems

    By Jared Dashevsky| healthcarehuddle.com@ GRAND ROUNDSMark Cuban’s Cost Plus Drugs Company just announced a new partnership with Penn Medicine—their third health system partnership in under a year. If you’ve been a Huddler for a while, you know I’m a big fan of Cost Plus Drugs. Back in February 2024, I broke down their business model and why it’s shaking up the drug pricing game. With this latest partnership making headlines, it’s the perfect time to dive back into Cost Plus Drugs.

    By Jared Dashevsky · healthcarehuddle.com

    Dec. 08, 2024

As seen in

Company Info

Healthcare Huddle

New York, New York, United States

+1 800-799-7233